Ms. Wade was the first non-executive Board member for Naegis and brings her wealth of knowledge and experience with transactions in the biopharmaceuticial industry. She is a partner with Dentons Canada LLP. Her practice is focused in the areas of corporate and securities law with an expertise in merger and acquisitions, general corporate advice, public and private financings, corporate governance and corporate reorganizations. She is a former member of the Securities Law Advisory Committee for the British Columbia Securities Commission and was a senior staff member at the Ontario Securities Commission from 1990-1994. Catherine has extensive experience advising biotechnology and life sciences companies in all aspects, including licensing and collaboration transactions.